Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on BioNTech (BNTX)

April 27, 2026 6:47 AM
H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $130.00 price target on BioNTech (NASDAQ: BNTX).The analyst commented: "At ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments